Clinical trial
Kesimpta (Ofatumumab) Pregnancy Registry
NCT05634967
Study timeline
Study start (actual)2023-01-05Date precision: day
Registry last updated2025-01-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Pregnancyunresolved
Interventions
KesimptaOTHER
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05634967 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.